Revolutionising diagnosis and prognosis of neurological conditions

At Neuronostics we are reimagining the way neurological conditions are diagnosed, treated, and monitored. We use the power of mathematical modelling to develop novel biomarkers that create faster paths to diagnosis and effective treatment.

Discover how BioEP can help:

BioEP - a novel digital biomarker of epilepsy

BioEP is a tool that provides objective decision support to healthcare professionals to help inform the likelihood of seizures, enabling faster and more accurate diagnosis and prognosis of epilepsy.

About us

Neuronostics was spun out of the University of Exeter in 2018. Our team are dedicated to developing novel biomarkers to help improve the lives of people living with neurological conditions. We are a diverse group with expertise in clinical, scientific, technology, operations and innovation fields. Supported by Innovate UK, NIHR and private equity, we won the Medilink UK National Start Up of the Year Award in 2020 and are currently focussed on trialling our technology in clinic.

Our Partners

Updates from Neuronostics

Here you can find our latest news, blogs, and press releases. For more regular updates about Neuronostics, please sign up to our newsletter below.

Find out more about how BioEP can help